Absolom K, Holch P, Woroncow B, Wright E P, Velikova G
Psychosocial Oncology and Clinical Practice Research Group, St James' Institute of Oncology, University of Leeds, Level 3, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK,
Qual Life Res. 2015 May;24(5):1077-85. doi: 10.1007/s11136-014-0909-z. Epub 2015 Jan 11.
In the UK, demonstration of patient and public involvement (PPI) is now a funding requirement. Despite advice being available to researchers regarding PPI, levels of engagement are variable. Patient involvement has been at the core of the Leeds Psychosocial Oncology and Clinical Practice Research Group since 2007 when a local Research Advisory Group (RAG) was established. In addition, we work with experienced patient advocates from national groups.
The RAG is led by designated researchers who manage and communicate with members. The RAG is invited to twice yearly meetings with the full research team when study findings are disseminated and advice sought. The meetings are also an opportunity to socialise and thank members. Effective partnerships and engagement require good communication, building relationships over time and tailoring involvement to individuals' skills and experience.
Patients have been involved in design, planning new projects and assisting with grant proposals; development, pilot testing of interview strategies and question generation, project steering groups and management teams, development of self-management advice for online patient portals; implementation, extensive beta testing of new questionnaire builder software to enable collection of online patient-reported outcomes (PRO) and study websites, cognitive interviews to develop PRO items; dissemination, co-authorship of papers and presentations, attendance/representation of the group at conferences.
The involvement of patient advocates is integral to ensuring PRO development remains patient-centred. Having a co-operative, well-established local PPI group and nationally active patient collaborators has had a rewarding and significant impact on our research programmes.
在英国,证明患者及公众参与(PPI)现已成为一项资金要求。尽管已向研究人员提供了有关PPI的建议,但参与程度仍存在差异。自2007年当地研究咨询小组(RAG)成立以来,患者参与一直是利兹心理社会肿瘤学与临床实践研究小组的核心。此外,我们还与全国性团体中有经验的患者权益倡导者合作。
RAG由指定的研究人员领导,他们负责管理并与成员沟通。当研究结果进行传播并征求建议时,RAG被邀请参加每年两次与整个研究团队的会议。这些会议也是社交和感谢成员的机会。有效的伙伴关系和参与需要良好的沟通,随着时间的推移建立关系,并根据个人技能和经验调整参与方式。
患者参与了设计、新项目规划以及协助撰写拨款申请;参与了访谈策略的开发、试点测试和问题生成、项目指导小组和管理团队;参与了为在线患者门户网站开发自我管理建议;参与了新问卷生成软件的广泛测试,以实现在线患者报告结局(PRO)的收集和研究网站建设,以及为开发PRO项目进行认知访谈;参与了论文和报告的共同撰写、小组在会议上的出席/代表。
患者权益倡导者的参与对于确保PRO的开发以患者为中心至关重要。拥有一个合作良好、成熟的本地PPI小组以及活跃于全国的患者合作者,对我们的研究项目产生了有益且重大的影响。